// App-Quantinova.ai

: Baseline EMBARK Data From EMERGE ENGAGE and PRIME Participants in the EMBARK Redosing Study

Researchers

Presenter

  • Sharon Cohen

Principal Investigators

  • Christopher H. van Dyck

  • Catherine J. Mummery

  • Anton Porsteinsson

  • Jessica Kong

  • Ryan Miller

  • Annie Racine

  • John O Gorman

  • Samantha Budd Haeberlein

  • Stephen Salloway

Medical Centers

  • Toronto Memory Program

  • Alzheimer’s Disease Research Unit, Yale School of Medicine

  • 4. UK Dementia Research Institute, Queen Square Institute of Neurology, University College London,

  • University of Rochester School of Medicine and Dentistry, Rochester, NY

  • Biogen

  • Departments of Neurology and Psychiatry, The Warren Alpert Medical School of Brown University

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • N/A

Drug/Treatment

  • Aducanumab

Outcome

  • N/A

Study Design

  • Open Label

Phase

  • NA

Study Id's

  • NCT04241068

  • NCT02484547

  • NCT02477800

  • NCT01677572

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved